Abstract Archives of the RSNA, 2014
VSPD31-13
Long-term Outcome of Percutaneous Transhepatic Balloon Angioplasty for Portal Vein Stenosis after Pediatric Living Donor Liver Transplantation
Scientific Papers
Presented on December 2, 2014
Presented as part of VSPD31: Pediatric Series: CV/IR
Minoru Yabuta MD, Presenter: Nothing to Disclose
Toshiya Shibata MD, Abstract Co-Author: Nothing to Disclose
Rinpei Imamine, Abstract Co-Author: Nothing to Disclose
Ken Shinozuka MD, Abstract Co-Author: Nothing to Disclose
Hiroyoshi Isoda MD, Abstract Co-Author: Nothing to Disclose
Kaori Togashi MD, PhD, Abstract Co-Author: Research Grant, Bayer AG
Research Grant, DAIICHI SANKYO Group
Research Grant, Eisai Co, Ltd
Research Grant, FUJIFILM Holdings Corporation
Research Grant, Nihon Medi-Physics Co, Ltd
Research Grant, Shimadzu Corporation
Research Grant, Toshiba Corporation
Research Grant, Covidien AG
To retrospectively evaluate the long-term outcomes of percutaneous transhepatic balloon angioplasty for portal vein stenosis after pediatric living donor liver transplantation.
Between October 1997 and December 2013, 43 patients (19 boys, 24 girls; mean age, 4.1 years) who had undergone living donor liver transplantation were confirmed to have portal vein stenosis at direct portography with or without manometry, and underwent percutaneous interventions, including balloon angioplasty with or without stent placement. Technical success, patency rates and major complications were evaluated. Follow-up periods after the initial balloon angioplasty ranged from 5 months to 169 months (mean, 119 months).
Technical success was achieved in 65 of 66 sessions (98.5%) and in 42 of 43 patients (97.7%). At 1, 3, 5, and 10 years after the first percutaneous transhepatic balloon angioplasty, the rates of primary patency were 83%, 78%, 76% and 70%, respectively, and the rates of primary-assisted patency were 100%, 100%, 100% and 96%, respectively. In major complication, severe asthma attack and portal vein thrombosis subsequent to balloon angioplasty were noted.
Percutaneous transhepatic balloon angioplasty for portal vein stenosis after pediatric living donor liver transplantation was safe and effective.
Percutaneous transhepatic balloon angioplasty might be a safe and effective treatment for portal vein stenosis after pediatric living donor liver transplantation.
Yabuta, M,
Shibata, T,
Imamine, R,
Shinozuka, K,
Isoda, H,
Togashi, K,
Long-term Outcome of Percutaneous Transhepatic Balloon Angioplasty for Portal Vein Stenosis after Pediatric Living Donor Liver Transplantation. Radiological Society of North America 2014 Scientific Assembly and Annual Meeting, - ,Chicago IL.
http://archive.rsna.org/2014/14000327.html